PillCam COLON 2 for investigation of the colon through direct visualisation | Diagnostics consultation | Diagnostics guidance | |
Enfortumab vedotin with pembrolizumab for untreated unresectable or metastatic urothelial cancer when platinum-based chemotherapy is suitable [ID6332] | Draft guidance | Technology appraisal guidance | |
Amivantamab with carboplatin and pemetrexed for untreated EGFR exon 20 insertion mutation-positive advanced non-small-cell lung cancer [ID5110] | Draft guidance | Technology appraisal guidance | |
Nemolizumab for treating prurigo nodularis [ID6451] | Draft guidance | Technology appraisal guidance | |
Nemolizumab for treating moderate to severe atopic dermatitis in people 12 years and over ID6221 | Draft guidance | Technology appraisal guidance | |
Durvalumab with platinum-based chemotherapy, then with or without olaparib, for treating newly diagnosed advanced or recurrent endometrial cancer ID6317 | Draft guidance | Technology appraisal guidance | |
Overweight and obesity management | Quality standard consultation | Quality standard | |
Intrapartum Care - maternal hyponatremia | Draft guidance consultation | NICE guideline | |
Pembrolizumab with carboplatin and paclitaxel for untreated advanced or recurrent endometrial cancer [ID6381] | Draft guidance | Technology appraisal guidance | |
Abortion Care | Draft guidance consultation | NICE guideline | |